Testing effectiveness (Phase 2)Study completedNCT04326257
What this trial is testing
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Dan Zandberg 20